Cargando…
Lipoprotein sialylation in atherosclerosis: Lessons from mice
Sialylation is a dynamically regulated modification, which commonly occurs at the terminal of glycan chains in glycoproteins and glycolipids in eukaryotic cells. Sialylation plays a key role in a wide array of biological processes through the regulation of protein–protein interactions, intracellular...
Autores principales: | Yu, Liming, Peng, Jun, Mineo, Chieko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498574/ https://www.ncbi.nlm.nih.gov/pubmed/36157440 http://dx.doi.org/10.3389/fendo.2022.953165 |
Ejemplares similares
-
Ghrelin Receptor Deficiency does not Affect Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice
por: Habegger, Kirk M., et al.
Publicado: (2011) -
Serum Linkage-Specific Sialylation Changes Are Potential Biomarkers for Monitoring and Predicting the Recurrence of Papillary Thyroid Cancer Following Thyroidectomy
por: Cao, Zhen, et al.
Publicado: (2022) -
Therapeutic Interference With Vascular Calcification—Lessons From Klotho-Hypomorphic Mice and Beyond
por: Lang, Florian, et al.
Publicado: (2018) -
OR24-6 Liver-Specific Inhibition of Sialic Acid Biosynthesis Improves Systemic Glucose Homeostasis in Mice
por: Holland, William, et al.
Publicado: (2022) -
Glycomic Analysis of High
Density Lipoprotein Shows
a Highly Sialylated Particle
por: Huang, Jincui, et al.
Publicado: (2014)